XML 16 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Total Stockholders' Equity of WSFS
Common Stock
Capital in Excess of Par Value
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Treasury Stock
Non-controlling Interest
Beginning balance (in shares) at Dec. 31, 2020     57,575,783          
Beginning balance at Dec. 31, 2020 $ 1,789,480 $ 1,791,726 $ 576 $ 1,053,022 $ 56,007 $ 977,414 $ (295,293) $ (2,246)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 215,204 215,155       215,155   49
Other comprehensive (loss) income (71,493) (71,493)     (71,493)      
Cash dividend (18,058) (18,058)       (18,058)    
Issuance of common stock including proceeds from exercise of common stock options (in shares)     59,119          
Issuance of common stock including proceeds from exercise of common stock options 526 526 $ 1 525        
Stock-based compensation expense 4,250 4,250   4,250        
Repurchases of common stock [1] (13,211) (13,211)   (1,183)     (12,028)  
Ending balance (in shares) at Sep. 30, 2021     57,634,902          
Ending balance at Sep. 30, 2021 1,906,698 1,908,895 $ 577 1,056,614 (15,486) 1,174,511 (307,321) (2,197)
Beginning balance (in shares) at Jun. 30, 2021     57,622,151          
Beginning balance at Jun. 30, 2021 1,881,811 1,884,054 $ 577 1,054,276 10,238 1,126,284 (307,321) (2,243)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 54,452 54,406       54,406   46
Other comprehensive (loss) income (25,724) (25,724)     (25,724)      
Cash dividend (6,179) (6,179)       (6,179)    
Issuance of common stock including proceeds from exercise of common stock options (in shares)     12,751          
Issuance of common stock including proceeds from exercise of common stock options 349 349   349        
Stock-based compensation expense 1,989 1,989   1,989        
Repurchases of common stock [1] 0              
Ending balance (in shares) at Sep. 30, 2021     57,634,902          
Ending balance at Sep. 30, 2021 1,906,698 1,908,895 $ 577 1,056,614 (15,486) 1,174,511 (307,321) (2,197)
Beginning balance (in shares) at Dec. 31, 2021     57,695,676          
Beginning balance at Dec. 31, 2021 1,937,016 1,939,099 $ 577 1,058,997 (37,768) 1,224,614 (307,321) (2,083)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 138,213 137,926       137,926   287
Other comprehensive (loss) income (677,711) (677,711)     (677,711)      
Cash dividend (26,501) (26,501)       (26,501)    
Contributions from noncontrolling shareholders (53)             (53)
Issuance of common stock including proceeds from exercise of common stock options (in shares)     83,830          
Issuance of common stock including proceeds from exercise of common stock options 2,519 2,519 $ 1 2,518        
Issuance of common stock in acquisition of BMT (in shares)     18,116,848          
Issuance of common stock in acquisition of BMT 908,016 908,016 $ 181 907,835        
Noncontrolling interest assumed in acquisition (913)             (913)
Stock-based compensation expense 4,427 4,427   4,427        
Repurchases of common stock [2] (184,182) (184,182)   (2,149)     (182,033)  
Ending balance (in shares) at Sep. 30, 2022     75,896,354          
Ending balance at Sep. 30, 2022 2,100,831 2,103,593 $ 759 1,971,628 (715,479) 1,336,039 (489,354) (2,762)
Beginning balance (in shares) at Jun. 30, 2022     75,870,300          
Beginning balance at Jun. 30, 2022 2,312,876 2,315,360 $ 759 1,968,175 (518,878) 1,272,192 (406,888) (2,484)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 73,344 73,382       73,382   (38)
Other comprehensive (loss) income (196,601) (196,601)     (196,601)      
Cash dividend (9,535) (9,535)       (9,535)    
Contributions from noncontrolling shareholders (240)             (240)
Issuance of common stock including proceeds from exercise of common stock options (in shares)     26,054          
Issuance of common stock including proceeds from exercise of common stock options 2,087 2,087   2,087        
Stock-based compensation expense 1,366 1,366   1,366        
Repurchases of common stock [3] (82,466) (82,466)         (82,466)  
Ending balance (in shares) at Sep. 30, 2022     75,896,354          
Ending balance at Sep. 30, 2022 $ 2,100,831 $ 2,103,593 $ 759 $ 1,971,628 $ (715,479) $ 1,336,039 $ (489,354) $ (2,762)
[1] Repurchase of common stock includes 267,309 shares repurchased in connection with the Company's share repurchase program approved by the Board of Directors and 18,348 shares withheld to cover tax liabilities.
[2] Repurchase of common stock includes 3,789,137 shares repurchased in connection with the Company's share repurchase program approved by the Board of Directors, and 104,965 shares withheld to cover tax liabilities.
[3] Repurchase of common stock includes 1,664,550 shares repurchased in connection with the Company's share repurchase program approved by the Board of Directors, and 4,872 shares withheld to cover tax liabilities.